Vadim Doronin

关注

立即认领

关注

立即认领

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 27 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Cusatuzumab Plus Azacitidine in Newly Diagnosed Acute Myeloid Leukaemia Ineligible for Intensive Chemotherapy (CULMINATE): Part One of a Randomised, Phase 2, Dose Optimisation Study

Thomas Pabst,Cristina Papayannidis,Fatih Demirkan,Vadim Doronin,Laura M. Fogliatto,Christina Guttke,Emmanuel Gyan,Nada Hamad,Pilar Herrera,Anna Hultberg,Julie Jacobs,Amy J. Johnson,Angelique Langlois,Xuewen Ma,Giovanni Martinelli,Montserrat Arnan,Rouven Mueller,Kerri Nottage,Yishai Ofran,Muhit Ozcan,Olga Samoilova,Jaszianne A. Tolbert, Geralyn C. Trudel,Liang Xiu, Norbert Vey,Andrew Wei

The lancet Haematologyno. 11 (2023): e902-e912

引用1浏览0WOS引用

Long-Term Outcomes from the Phase 3 OCEAN (OP-103) Study: Melflufen and Dexamethasone (dex) Versus Pomalidomide (pom) and Dex in Relapsed Refractory Multiple Myeloma (RRMM)

Fredrik Schjesvold,Meletios A. Dimopoulos,Sosana Delimpasi,Pawel Robak,Daniel Coriu,Wojciech Maciej Legiec,Ludek Pour,Ivan Spicka,Tamas Masszi,Vadim Anatolievich Doronin,Jiri Minarik,Galina Salogub,Yulia Alexeeva,Antonio Lazzaro,Vladimir Maisnar,Gabor Mikala,Stefan Norin,Marcus Thuresson, Anna Bergan,Jakob Obermuller,Roman Hajek,Maria-Victoria Mateos,Paul G. Richardson,Pieter Sonneveld

Bloodno. Supplement 1 (2023): 2018-2018

引用0浏览0引用

Enasidenib Vs Conventional Care in Older Patients with Late-Stage Mutant-Idh2 Relapsed/refractory AML: a Randomized Phase 3 Trial

Stephane de Botton,Pau Montesinos,Andre C. Schuh,Cristina Papayannidis,Paresh Vyas,Andrew H. Wei,Hans Ommen,Sergey Semochkin,Hee-Je Kim,Richard A. Larson, Jaime Koprivnikar,Olga Frankfurt,Felicitas Thol,Joerg Chromik,Jenny Byrne,Arnaud Pigneux,Xavier Thomas,Olga Salamero,Maria Belen Vidriales,Vadim Doronin,Hartmut Doehner,Amir T. Fathi,Eric Laille,Xin Yu,Maroof Hasan,Patricia Martin-Regueira,Courtney D. DiNardo

Blood（2023）

引用26浏览0WOS引用

Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study

Sosana Delimpasi,Maria Victoria Mateos,Holger W. Auner,Maria Gavriatopoulou,Meletios A. Dimopoulos,Hang Quach,Halyna Pylypenko,Roman Hajek,Xavier Leleu,Tuphan Kanti Dolai,Dinesh Kumar Sinha,Christopher P. Venner,Reuben Benjamin,Mamta Krishnan Garg,Vadim Doronin,Yair Levy,Philippe Moreau,Yi Chai,Melina Arazy,Jatin Shah, Sharon Shacham,Michael G. Kauffman,Paul G. Richardson,Sebastian Grosicki

AMERICAN JOURNAL OF HEMATOLOGY（2022）

引用5浏览0WOS引用

Melflufen or Pomalidomide Plus Dexamethasone for Patients with Multiple Myeloma Refractory to Lenalidomide (OCEAN): a Randomised, Head-to-head, Open-Label, Phase 3 Study

Fredrik H. Schjesvold,Meletios-Athanasios Dimopoulos,Sosana Delimpasi,Pawel Robak,Daniel Coriu,Wojciech Legiec,Ludek Pour,Ivan Spicka,Tamas Masszi,Vadim Doronin,Jiri Minarik,Galina Salogub,Yulia Alekseeva,Antonio Lazzaro,Vladimir Maisnar,Gabor Mikala,Laura Rosinol,Anna Marina Liberati,Argiris Symeonidis,Victoria Moody,Marcus Thuresson,Catriona Byrne,Johan Harmenberg,Nicolaas A. Bakker,Roman Hajek,Maria-Victoria Mateos,Paul G. Richardson,Pieter Sonneveld

The lancet Haematologyno. 2 (2022): e98-e110

引用37浏览0WOS引用

Pevonedistat Plus Azacitidine Vs Azacitidine Alone in Higher-Risk MDS/chronic Myelomonocytic Leukemia or Low-Blast-percentage AML

Lionel Ades,Larisa Girshova,Vadim A. Doronin,Maria Diez-Campelo,David Valcarcel,Suman Kambhampati,Nora-Athina Viniou,Dariusz Woszczyk,Raquel De Paz Arias,Argiris Symeonidis,Achilles Anagnostopoulos,Eduardo Ciliao Munhoz,Uwe Platzbecker,Valeria Santini,Robert J. Fram,Ying Yuan,Sharon Friedlander,Douglas Faller,Mikkael A. Sekeres

BLOOD ADVANCES（2022）

引用29浏览0WOS引用

Oral Ixazomib-Dexamethasone Vs Oral Pomalidomide-Dexamethasone for Lenalidomide-Refractory, Proteasome Inhibitor-Exposed Multiple Myeloma: a Randomized Phase 2 Trial

Meletios A. Dimopoulos,Fredrik Schjesvold,Vadim Doronin,Olga Vinogradova,Hang Quach,Xavier Leleu,Yolanda Gonzalez Montes,Karthik Ramasamy,Alessandra Pompa,Mark-David Levin,Cindy Lee,Ulf Henrik Mellqvist,Roland Fenk,Hélène Demarquette,Hamdi Sati,Alexander Vorog,Richard Labotka,Jichang Du,Mohamed Darif,Shaji Kumar

Blood cancer journal（2022）

引用12浏览0WOSNATURE引用

Isatuximab monotherapy in patients with refractory T-acute lymphoblastic leukemia or T-lymphoblastic lymphoma: Phase 2 study

Nicolas Boissel,Patrice Chevallier,Vadim Doronin,Laimonas Griskevicius,Alexey Maschan,James McCloskey,Alessandro Rambaldi,Giuseppe Rossi,Andrey Sokolov,Ulla Wartiovaara-Kautto,Corina Oprea,Giovanni Abbadessa,Alice Gosselin,Sandrine Mace,Xavier Thomas

CANCER MEDICINE（2022）

引用7浏览0WOS引用

Pevonedistat (PEV) + Azacitidine (AZA) Versus AZA Alone As First-Line Treatment for Patients with Higher-Risk Myelodysplastic Syndromes (mds)/chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) with 20-30% Marrow Blasts: the Randomized Phase 3 PANTHER Trial (NCT03268954)

Mikkael A. Sekeres,Larisa Girshova,Vadim A Doronin,Maria Diez-Campelo,David Valcarcel,Suman Kambhampati,Nora-Athina Viniou,Dariusz Woszczyk,Raquel De Paz Arias,Argiris Symeonidis,Achilles Anagnostopoulos,Eduardo Ciliao Munhoz,Uwe Platzbecker,Valeria Santini,Robert J. Fram,Ying Yuan,Douglas V. Faller,Lionel Ades

Blood（2021）

引用10浏览0引用

Oral ixazomib-dexamethasone versus oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma (MM) patients: A global, multicenter, randomized, open-label, phase 2 trial

Meletios A. Dimopoulos,Fredrik Schjesvold,Vadim Doronin,Olga Vinogradova,Hang Quach,Xavier Leleu,Gonzalez Montes Yolanda,Karthik Ramasamy,Alessandra Pompa,Mark-David Levin,Cindy Lee,Ulf-Henrik Mellqvist,Roland Fenk,Hamdi Sati,Alexander Vorog,Richard J. Labotka,Jichang Du,Mohamed Darif,Shaji Kumar

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用2浏览0引用

加载更多

作者统计

#Papers: 27

#Citation: 532

H-Index: 10

G-Index: 23

Sociability: 6

Diversity: 2

Activity: 24

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn